SharonAI Q2: $430M Net Loss Tied to Non-Cash Charge, Material Weakness Lingers, $8.8B Backlog
SHAZ has more than doubled off its 52-week low of $16.55.
Summary
A $430M Q2 net loss, driven by a non-cash fair value adjustment on convertible notes, contrasts with an $8.8B contract value. Material weakness in internal controls remains.
Key Events · Earnings and Guidance · SHAZ
-
Q2 Net Loss of $430M
The quarter's $430.4 million net loss includes a $400.4 million non-cash fair value loss on convertible notes, reflecting the impact of share price appreciation. Stripping out non-cash items, adjusted EBITDA came in at $0.6 million.
-
Material Weakness Continues
As of June 30, 2026, management acknowledged that a material weakness in internal control over financial reporting—stemming from complex financial instruments—remains unresolved. Disclosure controls and procedures were also deemed ineffective.
-
$8.8B Total Contract Value
By August 6, 2026, total contract value had climbed to approximately $8.8 billion, anchored by a $4.9 billion collaboration with NVIDIA and a $1.32 billion agreement with a global AI lab.
-
Strong Cash Position
Cash and cash equivalents totaled $1.86 billion at June 30, 2026, bolstered by $2.04 billion in financing activities during the first half of the year.
Analysis · SHAZ · Technology
SharonAI's second quarter paints a picture of extremes. A $430 million net loss was fueled almost entirely by a $400 million non-cash fair value adjustment on convertible notes—a paper loss triggered by the stock's climb. Meanwhile, the company sits on $1.86 billion in cash and has amassed an $8.8 billion total contract value. Yet the persistence of a material weakness in internal controls and ineffective disclosure controls is a serious concern for a firm scaling at this velocity. The non-cash charge does not drain cash, but the control deficiencies undermine confidence in financial reporting just as billions are being deployed.
At the time of this filing, SHAZ was trading at $53.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $16.55 to $97.48. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.